Literature DB >> 10383091

Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet.

K J Seymour1, S Bluml, J Sutherling, W Sutherling, B D Ross.   

Abstract

Ketogenic diet (KD) is highly effective in controlling epileptic seizures in children. One of the mechanisms postulated, the accumulation of ketone bodies, acetoacetate (AcAc) and/or betahydroxybutyrate (beta-OHB) in the brain, would be detectable by non-invasive proton magnetic resonance spectroscopy (1H-MRS). 1H-MRS was performed in occipital cortical grey matter in 14 epileptics (E); ages 3.8-48.3 years), seven KD and seven without, and 16 healthy age-matched subjects. One E was examined before and after KD. A singlet resonance (sigma = 2.22 ppm), distinct from AcAc (sigma = 2.26 and 3.46 ppm), and identified as acetone was present in all spectra of children on KD (nine spectra in five children; concentration 0.7 +/- 0.2 mM). This resonance was absent from Control and E without diet. AcAc and beta-OHB, which were not detectable in KD brain, were found in urine or blood of all KD. Seizures were well controlled in all E in whom acetone was detected. Two of seven E, both adults, were seizure-free without detectable acetone. Cerebral acetone may contribute to seizure control in KD, but is unlikely to be the sole mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383091     DOI: 10.1007/bf02590633

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  16 in total

1.  In vivo lactate and beta-hydroxybutyrate editing using a pure-phase refocusing pulse train.

Authors:  J Shen; E J Novotny; D L Rothman
Journal:  Magn Reson Med       Date:  1998-11       Impact factor: 4.668

2.  A proton magnetic resonance spectroscopy study of focal epilepsy in humans.

Authors:  P M Matthews; F Andermann; D L Arnold
Journal:  Neurology       Date:  1990-06       Impact factor: 9.910

3.  Plasma lipids in epileptic children treated with the high fat diet.

Authors:  A S Dekaban
Journal:  Arch Neurol       Date:  1966-08

Review 4.  Alternative epilepsy therapies: the ketogenic diet, immunoglobulins, and steroids.

Authors:  A N Prasad; C F Stafstrom; G L Holmes
Journal:  Epilepsia       Date:  1996       Impact factor: 5.864

5.  1H magnetic resonance spectroscopy in the investigation of intractable epilepsy.

Authors:  D G Gadian; A Connelly; J S Duncan; J H Cross; F J Kirkham; C L Johnson; F Vargha-Khadem; B G Nevile; G D Jackson
Journal:  Acta Neurol Scand Suppl       Date:  1994

6.  Chronic ketosis and cerebral metabolism.

Authors:  D C DeVivo; M P Leckie; J S Ferrendelli; D B McDougal
Journal:  Ann Neurol       Date:  1978-04       Impact factor: 10.422

7.  Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases.

Authors:  S L Kinsman; E P Vining; S A Quaskey; D Mellits; J M Freeman
Journal:  Epilepsia       Date:  1992 Nov-Dec       Impact factor: 5.864

8.  The redox state of free nicotinamide-adenine dinucleotide in the cytoplasm and mitochondria of rat liver.

Authors:  D H Williamson; P Lund; H A Krebs
Journal:  Biochem J       Date:  1967-05       Impact factor: 3.857

9.  Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study.

Authors:  J S Videen; T Michaelis; P Pinto; B D Ross
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

10.  Ketogenic diets in the treatment of epilepsy: short-term clinical effects.

Authors:  R H Schwartz; J Eaton; B D Bower; A Aynsley-Green
Journal:  Dev Med Child Neurol       Date:  1989-04       Impact factor: 5.449

View more
  23 in total

Review 1.  MR spectroscopy and spectroscopic imaging of the brain.

Authors:  He Zhu; Peter B Barker
Journal:  Methods Mol Biol       Date:  2011

Review 2.  Ketone bodies in epilepsy.

Authors:  Melanie A McNally; Adam L Hartman
Journal:  J Neurochem       Date:  2012-02-07       Impact factor: 5.372

Review 3.  The ketogenic diet in a pill: is this possible?

Authors:  Jong M Rho; Raman Sankar
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

Review 4.  Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

Authors:  Susan A Masino; Jonathan D Geiger
Journal:  Trends Neurosci       Date:  2008-05-09       Impact factor: 13.837

5.  Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: 1H-MRS study.

Authors:  Moran Artzi; Gilad Liberman; Nachum Vaisman; Felix Bokstein; Faina Vitinshtein; Orna Aizenstein; Dafna Ben Bashat
Journal:  J Neurooncol       Date:  2017-01-10       Impact factor: 4.130

6.  Postmortem 1H-MRS-Detection of Ketone Bodies and Glucose in Diabetic Ketoacidosis.

Authors:  Jakob Heimer; Dominic Gascho; Vasiliki Chatzaraki; Damaris Fröhlich Knaute; Vera Sterzik; Rosa Maria Martinez; Michael J Thali; Niklaus Zoelch
Journal:  Int J Legal Med       Date:  2017-11-23       Impact factor: 2.686

7.  Cerebral Ketones Detected by 3T MR Spectroscopy in Patients with High-Grade Glioma on an Atkins-Based Diet.

Authors:  A Berrington; K C Schreck; B J Barron; L Blair; D D M Lin; A L Hartman; E Kossoff; L Easter; C T Whitlow; Y Jung; F-C Hsu; M C Cervenka; J O Blakeley; P B Barker; R E Strowd
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-24       Impact factor: 3.825

8.  Brain ketones detected by proton magnetic resonance spectroscopy in an infant with Ohtahara syndrome treated with ketogenic diet.

Authors:  Kim M Cecil; Sarah B Mulkey; Xiawei Ou; Charles M Glasier
Journal:  Pediatr Radiol       Date:  2014-06-08

9.  Metabolic autocrine regulation of neurons involves cooperation among pannexin hemichannels, adenosine receptors, and KATP channels.

Authors:  Masahito Kawamura; David N Ruskin; Susan A Masino
Journal:  J Neurosci       Date:  2010-03-17       Impact factor: 6.167

10.  Magnetic resonance spectroscopy in pediatric neuroradiology: clinical and research applications.

Authors:  Ashok Panigrahy; Marvin D Nelson; Stefan Blüml
Journal:  Pediatr Radiol       Date:  2009-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.